Ovarian cancer in your 20s is rare. Only about 4.4% of all ovarian cancer diagnoses occur in women aged 20 to 34, and the median age at diagnosis is 63. The vast majority of cases develop in women over 55, making this one of the least likely cancers to affect a young woman.
That said, “rare” doesn’t mean “impossible.” Understanding what types of ovarian cancer do show up in younger women, what symptoms to watch for, and who faces higher risk can help you make sense of the numbers.
The Numbers in Context
A woman’s lifetime risk of developing ovarian cancer is about 1 in 91, according to the American Cancer Society. That risk is not spread evenly across a lifetime. It climbs sharply after menopause, with rates highest between ages 55 and 64. Less than 1% of the most common type of ovarian cancer (epithelial) is found in women under 30.
To put it plainly: if you gathered 1,000 women diagnosed with ovarian cancer in a given year, roughly 44 of them would be between 20 and 34. The remaining 956 would be older. For someone currently in their 20s with no family history or known genetic risk, the chance of a diagnosis right now is extremely small.
The Type That Affects Young Women Is Different
When ovarian cancer does occur in a young woman, it’s often a fundamentally different disease than the one seen in older women. About 90% of all ovarian cancers are epithelial tumors, which grow from the cells lining the surface of the ovary. These peak between ages 60 and 65.
In women between 10 and 30, the picture flips. Germ cell tumors, which develop from the egg-producing cells, account for roughly 70% of ovarian tumors in this age group. These tumors behave differently and generally respond well to treatment. In younger women under 30, the five-year survival rate across all stages is about 79%, compared to 59% for women aged 30 to 60 and 35% for women over 60. The biology of the tumors and earlier stage at diagnosis both contribute to that gap.
Another category worth knowing about is borderline tumors (sometimes called low malignant potential tumors). These are abnormal growths that look somewhat like cancer under a microscope but grow much more slowly. In one study of women under 40 with epithelial ovarian tumors, 75% had borderline tumors rather than fully invasive ones. Despite the reassuring name, borderline tumors still require treatment and monitoring.
Symptoms Are Easy to Dismiss
One of the biggest challenges with ovarian cancer at any age is that its symptoms overlap with dozens of everyday complaints. The most commonly reported signs include persistent bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, and frequent or urgent urination. In young women especially, these tend to be brushed off as digestive issues, urinary tract infections, or stress.
Research into diagnostic experiences shows a pattern of misattribution. Women have been repeatedly treated for urinary infections, told their symptoms were caused by yeast infections, or even diagnosed with depression and prescribed psychiatric medication before anyone considered an ovarian problem. Doctors don’t expect to see ovarian cancer in a 25-year-old, so it often isn’t on the radar during early visits.
The key distinction isn’t any single symptom but persistence. Bloating that lasts most days for two to three weeks, pelvic pressure that doesn’t come and go with your menstrual cycle, or a noticeable change in how quickly you feel full when eating are all worth mentioning to your doctor, especially if they’re new and don’t resolve.
Genetic Risk: When Family History Matters
The single biggest factor that could make ovarian cancer more likely in a young woman is an inherited gene mutation, particularly in the BRCA1 gene. In a Japanese study of women with known BRCA mutations, there were cases of ovarian cancer in BRCA1 carriers in their late 20s. Among BRCA2 carriers, no one developed ovarian cancer before age 40.
That’s a meaningful distinction. BRCA1 mutations carry a higher and earlier-onset risk for ovarian cancer than BRCA2 mutations, though both raise lifetime risk significantly. If you have a first-degree relative (mother, sister) who was diagnosed with ovarian or breast cancer, or if there’s a pattern of these cancers on either side of your family, genetic counseling can help you understand whether testing makes sense.
For women without known genetic risk factors, there is no recommended routine screening for ovarian cancer. The U.S. Preventive Services Task Force specifically advises against screening in low-risk, asymptomatic women because the available tests (blood markers and ultrasound) produce too many false positives without improving outcomes. For high-risk women with known mutations, doctors may use transvaginal ultrasound and a blood test called CA-125 as part of a monitoring plan.
What This Means for You
If you’re in your 20s and worried about ovarian cancer, the statistics are strongly in your favor. This is not a common cancer in young women by any measure. The rare cases that do occur tend to be a different, more treatable type than the disease associated with older women, and survival rates are considerably better.
What you can do is stay aware of your body’s baseline. Know what’s normal for your digestion, your menstrual cycle, and your urinary habits so you can recognize when something changes and sticks around. If you have a family history of ovarian or breast cancer, bring it up with your doctor to discuss whether genetic counseling is appropriate. Beyond that, there’s no screening test, supplement, or lifestyle change proven to prevent ovarian cancer in young, low-risk women.